研究用抗体・試薬の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

研究用抗体・試薬市場の世界需要は、2023年の119億7,000万米ドルから2032年には226億6,000万米ドル近くの市場規模に達すると推定され、調査期間2024年～2032年のCAGRは7.35%です。

研究用抗体・試薬は、生物学的プロセス、疾患、細胞メカニズムの科学的研究に不可欠なツールです。ユニークな抗原に結合するように特別に設計された抗体によって、研究者は複雑な生物学的サンプル内の特定のタンパク質や分子を検出し、定量することができます。緩衝液、染色剤、その他の化合物を含む試薬は、免疫組織化学、ELISA、ウェスタンブロッティングなどの様々な実験技術を促進します。これらの製品を組み合わせることで、生物医学研究における詳細な調査と分析が可能になり、知識の向上と新たな治療戦略の開発に貢献します。

市場力学

研究の再現性を高めるための高品質抗体への需要の高まりは、研究用抗体・試薬市場の成長を促す主な要因の一つです。さらに、医療・健康分野の研究開発への投資の増加は、研究用抗体・試薬市場の成長を促進すると予想されます。ヘルスケアや製薬分野でのバイオサイエンスやバイオテクノロジーの応用の拡大が需要を牽引しています。さらに、ライフサイエンス産業への投資の増加が、研究用抗体・試薬のニーズを高めています。さらに、産学連携の増加や幹細胞・神経生物学研究分野の盛り上がりが、研究用抗体・試薬市場にさらなる影響を与えています。しかし、潜在的な抗体の同定と市場開拓に関連する高いコストと時間が市場成長の妨げになると予想されます。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは研究用抗体・試薬の世界市場における各セグメントを包括的に評価することもできます。研究用抗体・試薬業界の成長と動向は、この調査に全体的なアプローチを提供します。

市場セグメンテーション

研究用抗体・試薬市場レポートのこのセクションでは、国・地域レベルのセグメントに関する詳細なデータを提供することで、戦略家がそれぞれの製品またはサービスのターゲット層を特定し、今後のビジネスチャンスに役立てることができます。

製品別

• 試薬（培地・血清、染色・色素、固定化剤、緩衝液、溶媒、酵素、プローブ、その他試薬）
• 抗体

タイプ別

• 一次抗体
• 二次抗体

形態別

• モノクローナル
• ポリクローナル
• 組み換え

ソース別

• マウス
• ウサギ
• その他のソース

研究領域別

• 腫瘍学
• 感染症学
• 免疫学
• 神経生物学
• 幹細胞
• その他の研究分野

技術別

• ウェスタンブロッティング
• フローサイトメトリー
• 酵素結合免疫吸着測定法（エリサ）
• 免疫組織化学
• 免疫蛍光
• 免疫沈降
• その他の技術

用途別

• プロテオミクス
• 医薬品開発
• ゲノミクス

エンドユーザー別

• 製薬・バイオテクノロジー
• 学術・研究機関
• 受託研究機関

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける研究用抗体・試薬市場の現在および将来の需要について、地域別の展望を取り上げます。さらに、本レポートは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

• 市場のハイライト
• 世界市場スナップショット

第3章 研究用抗体・試薬- 産業分析

• イントロダクション-市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 業界動向
• ポーターのファイブフォース分析
• 市場の魅力分析

第4章 バリューチェーン分析

• バリューチェーン分析
• 原材料分析
  • 原材料リスト
  • 原材料メーカーリスト
  • 主要原材料の価格動向
• 潜在的バイヤーのリスト
• マーケティングチャネル
  • ダイレクトマーケティング
  • インダイレクトマーケティング
  • マーケティングチャネル発展動向

第5章 研究用抗体・試薬の世界市場売上高：製品別

• 製品別概要
• 売上実績と予測分析
• 製品別分析
• 試薬（培地・血清、染色・色素、固定化剤、緩衝液、溶媒、酵素、プローブ、その他試薬）
• 抗体

第6章 研究用抗体・試薬の世界市場分析：タイプ別

• タイプ別概要
• 売上実績と予測分析
• タイプ別分析
• 一次抗体
• 二次抗体

第7章 研究用抗体・試薬の世界市場分析：形態別

• 形態別概要
• 売上実績と予測分析
• 形態別分析
• モノクローナル
• ポリクローナル
• リコンビナント

第8章 研究用抗体・試薬の世界市場分析：供給源別

• 供給源別概要
• 売上実績と予測分析
• 供給源別分析
• マウス
• ウサギ
• その他の供給源

第9章 世界の研究用抗体・試薬市場分析：研究分野別

• 研究分野別概要
• 売上実績と予測分析
• 研究領域別分析
• がん領域
• 感染症
• 免疫学
• 神経生物学
• 幹細胞
• その他の研究分野

第10章 研究用抗体・試薬の世界市場分析：技術別

• 技術別概要
• 売上実績と予測分析
• 技術別分析
• ウェスタンブロッティング
• フローサイトメトリー
• 酵素結合免疫吸着測定法（Elisa）
• 免疫組織化学
• 免疫蛍光法
• 免疫沈降
• その他の技術

第11章 研究用抗体・試薬の世界市場分析：用途別

• 概要：用途別
• 売上実績と予測分析
• 分析：用途別
• プロテオミクス
• 医薬品開発
• ゲノミクス

第12章 研究用抗体・試薬の世界市場分析：医薬品開発別

• エンドユーザー別概要
• 売上実績と予測分析
• エンドユーザー別分析
• 製薬・バイオテクノロジー産業
• 学術・研究機関
• 受託研究機関

第13章 研究用抗体・試薬の世界市場分析：地域別

• 地域別展望
• イントロダクション
• 北米売上分析
  • 概要、実績と予測
  • 北米：セグメント別
  • 北米国別
  • 米国
  • カナダ
  • メキシコ
• 欧州売上分析
  • 概要、実績と予測
  • 欧州セグメント別
  • 欧州：国別
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • ロシア
  • その他欧州
• アジア太平洋売上分析
  • 概要、実績と予測
  • アジア太平洋：セグメント別
  • アジア太平洋：国別
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • 東南アジア
  • その他アジア太平洋
• ラテンアメリカ売上分析
  • 概要、実績と予測
  • ラテンアメリカ：セグメント別
  • ラテンアメリカ：国別
  • ブラジル
  • アルゼンチン
  • ペルー
  • チリ
  • その他ラテンアメリカ
• 中東・アフリカ売上分析
  • 概要、実績と予測
  • 中東・アフリカ：セグメント別
  • 中東・アフリカ：国別
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東とアフリカ

第14章 研究用抗体・試薬企業の競合情勢

• 研究用抗体・試薬市場の競合
• 提携・協力・協定
• 合併・買収
• 新製品上市
• その他の開発

第15章 企業プロファイル

• 企業シェア分析
• 市場集中度
• Thermo Fisher Scientific Inc.（US）
• Merck KGaA（Germany）
• Abcam Plc（UK）
• Becton, Dickinson Company（US）
• BioLegend（US）
• GenScript（China）
• Bio-Rad Laboratories（US）
• Cell Signaling Technology（US）
• F. Hoffmann-La Roche（Switzerland）
• Danaher Corporation（US）
• Agilent Technologies（US）
• PerkinElmer（US）
• Lonza（Switzerland）

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Reagent (Media & Sera, Stains & Dyes, Fixatives, Buffers, Solvents, Enzymes, Probes, Other Reagents) Market Sales by Geography (USD MN)
• Antibodies Market Sales by Geography (USD MN)
• Analysis Market by Type (USD MN)
• Primary Antibodies Market Sales by Geography (USD MN)
• Secondary Antibodies Market Sales by Geography (USD MN)
• Analysis by Form (USD MN)
• Monoclonal Market Sales by Geography (USD MN)
• Polyclonal Market Sales by Geography (USD MN)
• Recombinant Market Sales by Geography (USD MN)
• Analysis by Source (USD MN)
• Mice Market Sales by Geography (USD MN)
• Rabbits Market Sales by Geography (USD MN)
• Other Sources Market Sales by Geography (USD MN)
• Analysis by Research Area (USD MN)
• Oncology Market Sales by Geography (USD MN)
• Infectious Diseases Market Sales by Geography (USD MN)
• Immunology Market Sales by Geography (USD MN)
• Neurobiology Market Sales by Geography (USD MN)
• Stem Cells Market Sales by Geography (USD MN)
• Other Research Areas Market Sales by Geography (USD MN)
• Analysis by Technology (USD MN)
• Western Blotting Market Sales by Geography (USD MN)
• Flow Cytometry Market Sales by Geography (USD MN)
• Enzyme-Linked Immunosorbent Assay (Elisa) Market Sales by Geography (USD MN)
• Immunohistochemistry Market Sales by Geography (USD MN)
• Immunofluorescence Market Sales by Geography (USD MN)
• Immunoprecipitation Market Sales by Geography (USD MN)
• Other Technologies Market Sales by Geography (USD MN)
• Analysis by Application (USD MN)
• Proteomics Market Sales by Geography (USD MN)
• Drug Development Market Sales by Geography (USD MN)
• Genomics Market Sales by Geography (USD MN)
• Analysis by End User (USD MN)
• Pharmaceutical & Biotechnologies Industries Market Sales by Geography (USD MN)
• Academic & Research Institutions Market Sales by Geography (USD MN)
• Contract Research Organizations Market Sales by Geography (USD MN)
• Global Research Antibodies & Reagents Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Research Antibodies & Reagents Report
• Market Research Process
• Market Research Methodology
• Global Research Antibodies & Reagents Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Type
• Market Attractiveness Analysis by Form
• Market Attractiveness Analysis by Source
• Market Attractiveness Analysis by Research Area
• Market Attractiveness Analysis by Technology
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by End User
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Reagent (Media & Sera, Stains & Dyes, Fixatives, Buffers, Solvents, Enzymes, Probes, Other Reagents) Market Sales by Geography (USD MN)
• Antibodies Market Sales by Geography (USD MN)
• Global Market Analysis by Type (USD MN)
• Primary Antibodies Market Sales by Geography (USD MN)
• Secondary Antibodies Market Sales by Geography (USD MN)
• Global Market Analysis by Form (USD MN)
• Monoclonal Market Sales by Geography (USD MN)
• Polyclonal Market Sales by Geography (USD MN)
• Recombinant Market Sales by Geography (USD MN)
• Global Market Analysis by Source (USD MN)
• Mice Market Sales by Geography (USD MN)
• Rabbits Market Sales by Geography (USD MN)
• Other Sources Market Sales by Geography (USD MN)
• Global Market Analysis by Research Area (USD MN)
• Oncology Market Sales by Geography (USD MN)
• Infectious Diseases Market Sales by Geography (USD MN)
• Immunology Market Sales by Geography (USD MN)
• Neurobiology Market Sales by Geography (USD MN)
• Stem Cells Market Sales by Geography (USD MN)
• Other Research Areas Market Sales by Geography (USD MN)
• Global Market Analysis by Technology (USD MN)
• Western Blotting Market Sales by Geography (USD MN)
• Flow Cytometry Market Sales by Geography (USD MN)
• Enzyme-Linked Immunosorbent Assay (Elisa) Market Sales by Geography (USD MN)
• Immunohistochemistry Market Sales by Geography (USD MN)
• Immunofluorescence Market Sales by Geography (USD MN)
• Immunoprecipitation Market Sales by Geography (USD MN)
• Other Technologies Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Proteomics Market Sales by Geography (USD MN)
• Drug Development Market Sales by Geography (USD MN)
• Genomics Market Sales by Geography (USD MN)
• Global Market Analysis by End User (USD MN)
• Pharmaceutical & Biotechnologies Industries Market Sales by Geography (USD MN)
• Academic & Research Institutions Market Sales by Geography (USD MN)
• Contract Research Organizations Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

The global demand for Research Antibodies & Reagents Market is presumed to reach the market size of nearly USD 22.66 Billion by 2032 from USD 11.97 Billion in 2023 with a CAGR of 7.35% under the study period 2024 - 2032.

Research antibodies & reagents are essential tools in the scientific study of biological processes, diseases, and cellular mechanisms. Antibodies specifically designed to bind to unique antigens allow researchers to detect and quantify specific proteins or molecules within complex biological samples. Reagents, including buffers, stains, and other chemical compounds, facilitate various experimental techniques such as immunohistochemistry, ELISA, and Western blotting. Together, these products enable detailed investigation and analysis in biomedical research, contributing to advancing knowledge and developing new therapeutic strategies.

MARKET DYNAMICS

The rise in demand for high-quality antibodies for research reproducibility is one of the major factors driving the growth of the research antibodies and reagents market. Moreover, rising investment in medical and health R&D is expected to fuel growth in the research antibodies and reagents market. The growing applications of biosciences and biotechnology in healthcare and pharmaceutical fields are driving demand. Furthermore, increased investment in the life sciences industry is driving up the need for research antibodies and reagents. Additionally, the increase in industry-academia collaboration and rising stem cell and neurobiology research field further influences the research antibodies and reagents market. However, the high cost and time related to identifying and developing potential antibodies are expected to hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Research Antibodies & Reagents. The growth and trends of Research Antibodies & Reagents industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Research Antibodies & Reagents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Reagent (Media & Sera, Stains & Dyes, Fixatives, Buffers, Solvents, Enzymes, Probes, Other Reagents)
• Antibodies

By Type

• Primary Antibodies
• Secondary Antibodies

By Form

• Monoclonal
• Polyclonal
• Recombinant

By Source

• Mice
• Rabbits
• Other Sources

By Research Area

• Oncology
• Infectious Diseases
• Immunology
• Neurobiology
• Stem Cells
• Other Research Areas

By Technology

• Western Blotting
• Flow Cytometry
• Enzyme-Linked Immunosorbent Assay (Elisa)
• Immunohistochemistry
• Immunofluorescence
• Immunoprecipitation
• Other Technologies

By Application

• Proteomics
• Drug Development
• Genomics

By End User

• Pharmaceutical & Biotechnologies Industries
• Academic & Research Institutions
• Contract Research Organizations

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Research Antibodies & Reagents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Research Antibodies & Reagents market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Abcam Plc (UK), Becton, Dickinson, Company (US), Bio-Rad Laboratories (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), GenScript (China), BioLegend (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . RESEARCH ANTIBODIES & REAGENTS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Type
  • 3.7.3 Market Attractiveness Analysis By Form
  • 3.7.4 Market Attractiveness Analysis By Source
  • 3.7.5 Market Attractiveness Analysis By Research Area
  • 3.7.6 Market Attractiveness Analysis By Technology
  • 3.7.7 Market Attractiveness Analysis By Application
  • 3.7.8 Market Attractiveness Analysis By End User
  • 3.7.9 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SALES BY PRODUCT

• 5.1 Overview by Product
• 5.2 Historical and Forecast Sales Data
• 5.3 Analysis by Product
• 5.4 Reagent (Media & Sera, Stains & Dyes, Fixatives, Buffers, Solvents, Enzymes, Probes, Other Reagents) Historic and Forecast Sales by Regions
• 5.5 Antibodies Historic and Forecast Sales by Regions

6 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY TYPE

• 6.1 Overview by Type
• 6.2 Historical and Forecast Sales Data
• 6.3 Analysis by Type
• 6.4 Primary Antibodies Historic and Forecast Sales by Regions
• 6.5 Secondary Antibodies Historic and Forecast Sales by Regions

7 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY FORM

• 7.1 Overview by Form
• 7.2 Historical and Forecast Sales Data
• 7.3 Analysis by Form
• 7.4 Monoclonal Historic and Forecast Sales by Regions
• 7.5 Polyclonal Historic and Forecast Sales by Regions
• 7.6 Recombinant Historic and Forecast Sales by Regions

8 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY SOURCE

• 8.1 Overview by Source
• 8.2 Historical and Forecast Sales Data
• 8.3 Analysis by Source
• 8.4 Mice Historic and Forecast Sales by Regions
• 8.5 Rabbits Historic and Forecast Sales by Regions
• 8.6 Other Sources Historic and Forecast Sales by Regions

9 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY RESEARCH AREA

• 9.1 Overview by Research Area
• 9.2 Historical and Forecast Sales Data
• 9.3 Analysis by Research Area
• 9.4 Oncology Historic and Forecast Sales by Regions
• 9.5 Infectious Diseases Historic and Forecast Sales by Regions
• 9.6 Immunology Historic and Forecast Sales by Regions
• 9.7 Neurobiology Historic and Forecast Sales by Regions
• 9.8 Stem Cells Historic and Forecast Sales by Regions
• 9.9 Other Research Areas Historic and Forecast Sales by Regions

10 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY TECHNOLOGY

• 10.1 Overview by Technology
• 10.2 Historical and Forecast Sales Data
• 10.3 Analysis by Technology
• 10.4 Western Blotting Historic and Forecast Sales by Regions
• 10.5 Flow Cytometry Historic and Forecast Sales by Regions
• 10.6 Enzyme-Linked Immunosorbent Assay (Elisa) Historic and Forecast Sales by Regions
• 10.7 Immunohistochemistry Historic and Forecast Sales by Regions
• 10.8 Immunofluorescence Historic and Forecast Sales by Regions
• 10.9 Immunoprecipitation Historic and Forecast Sales by Regions
• 10.1 Other Technologies Historic and Forecast Sales by Regions

11 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY APPLICATION

• 11.1 Overview by Application
• 11.2 Historical and Forecast Sales Data
• 11.3 Analysis by Application
• 11.4 Proteomics Historic and Forecast Sales by Regions
• 11.5 Drug Development Historic and Forecast Sales by Regions
• 11.6 Genomics Historic and Forecast Sales by Regions

12 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY DRUG DEVELOPMENT

• 12.1 Overview by End User
• 12.2 Historical and Forecast Sales Data
• 12.3 Analysis by End User
• 12.4 Pharmaceutical & Biotechnologies Industries Historic and Forecast Sales by Regions
• 12.5 Academic & Research Institutions Historic and Forecast Sales by Regions
• 12.6 Contract Research Organizations Historic and Forecast Sales by Regions

13 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY GEOGRAPHY

• 13.1. Regional Outlook
• 13.2. Introduction
• 13.3. North America Sales Analysis
  • 13.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 13.3.2. North America By Segment Sales Analysis
  • 13.3.3. North America By Country Sales Analysis
  • 13.3.4. United State Sales Analysis
  • 13.3.5. Canada Sales Analysis
  • 13.3.6. Mexico Sales Analysis
• 13.4. Europe Sales Analysis
  • 13.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 13.4.2. Europe by Segment Sales Analysis
  • 13.4.3. Europe by Country Sales Analysis
  • 13.4.4. United Kingdom Sales Analysis
  • 13.4.5. France Sales Analysis
  • 13.4.6. Germany Sales Analysis
  • 13.4.7. Italy Sales Analysis
  • 13.4.8. Russia Sales Analysis
  • 13.4.9. Rest Of Europe Sales Analysis
• 13.5. Asia Pacific Sales Analysis
  • 13.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 13.5.2. Asia Pacific by Segment Sales Analysis
  • 13.5.3. Asia Pacific by Country Sales Analysis
  • 13.5.4. China Sales Analysis
  • 13.5.5. India Sales Analysis
  • 13.5.6. Japan Sales Analysis
  • 13.5.7. South Korea Sales Analysis
  • 13.5.8. Australia Sales Analysis
  • 13.5.9. South East Asia Sales Analysis
  • 13.5.10. Rest Of Asia Pacific Sales Analysis
• 13.6. Latin America Sales Analysis
  • 13.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 13.6.2. Latin America by Segment Sales Analysis
  • 13.6.3. Latin America by Country Sales Analysis
  • 13.6.4. Brazil Sales Analysis
  • 13.6.5. Argentina Sales Analysis
  • 13.6.6. Peru Sales Analysis
  • 13.6.7. Chile Sales Analysis
  • 13.6.8. Rest of Latin America Sales Analysis
• 13.7. Middle East & Africa Sales Analysis
  • 13.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 13.7.2. Middle East & Africa by Segment Sales Analysis
  • 13.7.3. Middle East & Africa by Country Sales Analysis
  • 13.7.4. Saudi Arabia Sales Analysis
  • 13.7.5. UAE Sales Analysis
  • 13.7.6. Israel Sales Analysis
  • 13.7.7. South Africa Sales Analysis
  • 13.7.8. Rest Of Middle East And Africa Sales Analysis

14 . COMPETITIVE LANDSCAPE OF THE RESEARCH ANTIBODIES & REAGENTS COMPANIES

• 14.1. Research Antibodies & Reagents Market Competition
• 14.2. Partnership/Collaboration/Agreement
• 14.3. Merger And Acquisitions
• 14.4. New Product Launch
• 14.5. Other Developments

15 . COMPANY PROFILES OF RESEARCH ANTIBODIES & REAGENTS INDUSTRY

• 15.1. Company Share Analysis
• 15.2. Market Concentration Rate
• 15.3. Thermo Fisher Scientific Inc. (US)
  • 15.3.1. Company Overview
  • 15.3.2. Company Revenue
  • 15.3.3. Products
  • 15.3.4. Recent Developments
• 15.4. Merck KGaA (Germany)
  • 15.4.1. Company Overview
  • 15.4.2. Company Revenue
  • 15.4.3. Products
  • 15.4.4. Recent Developments
• 15.5. Abcam Plc (UK)
  • 15.5.1. Company Overview
  • 15.5.2. Company Revenue
  • 15.5.3. Products
  • 15.5.4. Recent Developments
• 15.6. Becton, Dickinson Company (US)
  • 15.6.1. Company Overview
  • 15.6.2. Company Revenue
  • 15.6.3. Products
  • 15.6.4. Recent Developments
• 15.7. BioLegend (US)
  • 15.7.1. Company Overview
  • 15.7.2. Company Revenue
  • 15.7.3. Products
  • 15.7.4. Recent Developments
• 15.8. GenScript (China)
  • 15.8.1. Company Overview
  • 15.8.2. Company Revenue
  • 15.8.3. Products
  • 15.8.4. Recent Developments
• 15.9. Bio-Rad Laboratories (US)
  • 15.9.1. Company Overview
  • 15.9.2. Company Revenue
  • 15.9.3. Products
  • 15.9.4. Recent Developments
• 15.10. Cell Signaling Technology (US)
  • 15.10.1. Company Overview
  • 15.10.2. Company Revenue
  • 15.10.3. Products
  • 15.10.4. Recent Developments
• 15.11. F. Hoffmann-La Roche (Switzerland)
  • 15.11.1. Company Overview
  • 15.11.2. Company Revenue
  • 15.11.3. Products
  • 15.11.4. Recent Developments
• 15.12. Danaher Corporation (US)
  • 15.12.1. Company Overview
  • 15.12.2. Company Revenue
  • 15.12.3. Products
  • 15.12.4. Recent Developments
• 15.13. Agilent Technologies (US)
  • 15.13.1. Company Overview
  • 15.13.2. Company Revenue
  • 15.13.3. Products
  • 15.13.4. Recent Developments
• 15.13. PerkinElmer (US)
  • 15.13.1. Company Overview
  • 15.13.2. Company Revenue
  • 15.13.3. Products
  • 15.13.4. Recent Developments
• 15.15. Lonza (Switzerland)
  • 15.15.1. Company Overview
  • 15.15.2. Company Revenue
  • 15.15.3. Products
  • 15.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies